Angiogenesis Inhibitors for the Treatment of Hepatocellular Carcinoma

Background: Angiogenesis inhibitors have become an important therapeutic approach in the treatment of hepatocellular carcinoma (HCC) patients. The therapeutic inhibition of angiogenesis of Sorafenib in increasing overall survival of patients with HCC is a fundamental element of the treatment of this...

Descripción completa

Detalles Bibliográficos
Autores principales: Berretta, Massimiliano, Rinaldi, Luca, Di Benedetto, Fabrizio, Lleshi, Arben, De Re, Vallì, Facchini, Gaetano, De Paoli, Paolo, Di Francia, Raffaele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2016
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5101236/
https://www.ncbi.nlm.nih.gov/pubmed/27881963
http://dx.doi.org/10.3389/fphar.2016.00428

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5101236/
https://www.ncbi.nlm.nih.gov/pubmed/27881963
http://dx.doi.org/10.3389/fphar.2016.00428

Ejemplares similares